"Designing Growth Strategies is in our DNA"

Anti-Inflammatory Biologics Market Size, Share & Industry Analysis, By Drug Class (Anti-Tumor Necrosis Factor (TNF), Interleukin Antagonists, Janus Kinase (JAK) Inhibitors, Others), By Application (Rheumatoid Arthritis, Psoriasis, and Others), By Route of Administration (Oral and Injection (Subcutaneous and Intravenous)), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027

Region : Global | Format: PDF | Report ID: FBI102733

 

Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Rheumatoid Arthritis & Psoriasis – For Key Countries
    2. Pipeline Analysis
    3. Patent Snapshot
    4. New Product Launches
    5. Key Industry Developments - Mergers, Acquisitions and Partnerships
  5. Global Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Anti-Tumor Necrosis Factor (TNF)
      2. Interleukin Antagonists
      3. Janus Kinase (JAK) Inhibitors
      4. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. Rheumatoid Arthritis
      2. Psoriasis
      3. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Subcutaneous
        2. Intravenous
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Anti-Tumor Necrosis Factor (TNF)
      2. Interleukin Antagonists
      3. Janus Kinase (JAK) Inhibitors
      4. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. Rheumatoid Arthritis
      2. Psoriasis
      3. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Subcutaneous
        2. Intravenous
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Anti-Tumor Necrosis Factor (TNF)
      2. Interleukin Antagonists
      3. Janus Kinase (JAK) Inhibitors
      4. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. Rheumatoid Arthritis
      2. Psoriasis
      3. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Subcutaneous
        2. Intravenous
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecast – By Countries/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Anti-Tumor Necrosis Factor (TNF)
      2. Interleukin Antagonists
      3. Janus Kinase (JAK) Inhibitors
      4. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. Rheumatoid Arthritis
      2. Psoriasis
      3. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Subcutaneous
        2. Intravenous
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecast – By Countries/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Anti-Tumor Necrosis Factor (TNF)
      2. Interleukin Antagonists
      3. Janus Kinase (JAK) Inhibitors
      4. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. Rheumatoid Arthritis
      2. Psoriasis
      3. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Subcutaneous
        2. Intravenous
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecast – By Countries/ Sub regions
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Anti-Tumor Necrosis Factor (TNF)
      2. Interleukin Antagonists
      3. Janus Kinase (JAK) Inhibitors
      4. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. Rheumatoid Arthritis
      2. Psoriasis
      3. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Injection
        1. Subcutaneous
        2. Intravenous
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecast – By Countries/ Sub region
      1. South Africa
      2. GCC
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Company Profiles (Overview, Product  & Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. AbbVie Inc.
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Johnson & Johnson Services, Inc.
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Bristol-Myers Squibb Company
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Merck & Co., Inc.
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Pfizer Inc.
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Novartis AG
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. UCB S.A.
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Eli Lilly and Company
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. Amgen Inc.
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. Biogen              
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      11. Other Prominent Players
        1. Overview,
        2. Product  & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations

List of Figures

Figure 1:  Global Anti-inflammatory Biologics Market Revenue Breakdown (US$ Bn, %) by Region, 2019 & 2027

Figure 2:  Global Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2019 & 2027

Figure 3:  Global Anti-inflammatory Biologics Market Forecast (US$ Bn), by Anti-Tumor Necrosis Factor (TNF), 2016-2027

Figure 4:  Global Anti-inflammatory Biologics Market Forecast (US$ Bn), by Interleukin Antagonists, 2016-2027

Figure 5:  Global Anti-inflammatory Biologics Market Forecast (US$ Bn), by Janus Kinase (JAK) Inhibitors, 2016-2027

Figure 6:  Global Anti-inflammatory Biologics Market Forecast (US$ Bn), by Others, 2016-2027

Figure 7:  Global Anti-inflammatory Biologics Market Value Share (%), by Application, 2019 & 2027

Figure 8:  Global Anti-inflammatory Biologics Market Forecast (US$ Bn), by Rheumatoid Arthritis, 2016-2027

Figure 9:  Global Anti-inflammatory Biologics Market Forecast (US$ Bn), by Psoriasis, 2016-2027

Figure 10:  Global Anti-inflammatory Biologics Market Forecast (US$ Bn), by Others, 2016-2027

Figure 11:  Global Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2019 & 2027

Figure 12:  Global Anti-inflammatory Biologics Market Forecast (US$ Bn), by Oral, 2016-2027

Figure 13:  Global Anti-inflammatory Biologics Market Forecast (US$ Bn), by Injection, 2016-2027

Figure 14:  Global Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2019 & 2027

Figure 15:  Global Anti-inflammatory Biologics Market Forecast (US$ Bn), by Hospital Pharmacy, 2016-2027

Figure 16:  Global Anti-inflammatory Biologics Market Forecast (US$ Bn), by Retail Pharmacy, 2016-2027

Figure 17:  Global Anti-inflammatory Biologics Market Forecast (US$ Bn), by Online Pharmacy, 2016-2027

Figure 18:  Global Anti-inflammatory Biologics Market Value (US$ Bn), by Region, 2019 & 2027

Figure 19:  North America Anti-inflammatory Biologics Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 20:  North America Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2019

Figure 21:  North America Anti-inflammatory Biologics Market Value (US$ Bn), by Application, 2019 & 2027

Figure 22:  North America Anti-inflammatory Biologics Market Value Share (%), by Application, 2019

Figure 23:  North America Anti-inflammatory Biologics Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 24:  North America Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2019

Figure 25:  North America Anti-inflammatory Biologics Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 26:  North America Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2019

Figure 27:  North America Anti-inflammatory Biologics Market Value (US$ Bn), By Country, 2019 & 2027

Figure 28:  North America Anti-inflammatory Biologics Market Value Share (%), By Country, 2019

Figure 29:  Europe Anti-inflammatory Biologics Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 30:  Europe Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2019

Figure 31:  Europe Anti-inflammatory Biologics Market Value (US$ Bn), by Application, 2019 & 2027

Figure 32:  Europe Anti-inflammatory Biologics Market Value Share (%), by Application, 2019

Figure 33:  Europe Anti-inflammatory Biologics Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 34:  Europe Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2019

Figure 35:  Europe Anti-inflammatory Biologics Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 36:  Europe Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2019

Figure 37:  Europe Anti-inflammatory Biologics Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 38:  Europe Anti-inflammatory Biologics Market Value Share (%), By Country/ Sub-region, 2019

Figure 39:  Asia Pacific Anti-inflammatory Biologics Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 40:  Asia Pacific Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2019

Figure 41:  Asia Pacific Anti-inflammatory Biologics Market Value (US$ Bn), by Application, 2019 & 2027

Figure 42:  Asia Pacific Anti-inflammatory Biologics Market Value Share (%), by Application, 2019

Figure 43:  Asia Pacific Anti-inflammatory Biologics Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 44:  Asia Pacific Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2019

Figure 45:  Asia Pacific Anti-inflammatory Biologics Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 46:  Asia Pacific Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2019

Figure 47:  Asia Pacific Anti-inflammatory Biologics Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 48:  Asia Pacific Anti-inflammatory Biologics Market Value Share (%), By Country/ Sub-region, 2019

Figure 49:  Latin America Anti-inflammatory Biologics Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 50:  Latin America Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2019

Figure 51:  Latin America Anti-inflammatory Biologics Market Value (US$ Bn), by Application, 2019 & 2027

Figure 52:  Latin America Anti-inflammatory Biologics Market Value Share (%), by Application, 2019

Figure 53:  Latin America Anti-inflammatory Biologics Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 54:  Latin America Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2019

Figure 55:  Latin America Anti-inflammatory Biologics Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 56:  Latin America Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2019

Figure 57:  Latin America Anti-inflammatory Biologics Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 58:  Latin America Anti-inflammatory Biologics Market Value Share (%), By Country/ Sub-region, 2019

Figure 59:  Middle East & Africa Anti-inflammatory Biologics Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 60:  Middle East & Africa Anti-inflammatory Biologics Market Value Share (%), by Drug Class, 2019

Figure 61:  Middle East & Africa Anti-inflammatory Biologics Market Value (US$ Bn), by Application, 2019 & 2027

Figure 62:  Middle East & Africa Anti-inflammatory Biologics Market Value Share (%), by Application, 2019

Figure 63:  Middle East & Africa Anti-inflammatory Biologics Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 64:  Middle East & Africa Anti-inflammatory Biologics Market Value Share (%), by Route of Administration, 2019

Figure 65:  Middle East & Africa Anti-inflammatory Biologics Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 66:  Middle East & Africa Anti-inflammatory Biologics Market Value Share (%), by Distribution Channel, 2019

Figure 67:  Middle East & Africa Anti-inflammatory Biologics Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 68:  Middle East & Africa Anti-inflammatory Biologics Market Value Share (%), By Country/ Sub-region, 2019

Figure 69:  Global Anti-inflammatory Biologics Market Share (%), By Company, 2019

List of Tables

Table 1:  Global Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Drug Class, 2016–2027

Table 2:  Global Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Application, 2016–2027

Table 3:  Global Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016–2027

Table 4:  Global Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Injection, 2016–2027

Table 5:  Global Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016–2027

Table 6:  Global Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Region, 2016-2027

Table 7:  North America Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 8:  North America Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Application, 2016-2027

Table 9:  North America Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 10:  North America Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Injection, 2016–2027

Table 11:  North America Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 12:  North America Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, By Country, 2016-2027

Table 13:  Europe Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 14:  Europe Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Application, 2016-2027

Table 15:  Europe Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 16:  Europe Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Injection, 2016–2027

Table 17:  Europe Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 18:  Europe Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 19:  Asia Pacific Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 20:  Asia Pacific Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Application, 2016-2027

Table 21:  Asia Pacific Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 22:  Asia Pacific Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Injection, 2016–2027

Table 23:  Asia Pacific Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 24:  Asia Pacific Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 25:  Latin America Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 26:  Latin America Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Application, 2016-2027

Table 27:  Latin America Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 28:  Latin America Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Injection, 2016–2027

Table 29:  Latin America Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 30:  Latin America Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 31:  Middle East & Africa Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 32:  Middle East & Africa Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Application, 2016-2027

Table 33:  Middle East & Africa Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 34:  Middle East & Africa Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Injection, 2016–2027

Table 35:  Middle East & Africa Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 36:  Middle East & Africa Anti-inflammatory Biologics Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

 class=
  • May, 2020
  • 2019
  • 2016-2018
  • 145

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X